|
| 1 | +--- |
| 2 | +name: industry-performance-snapshot |
| 3 | +description: Retrieve a daily overview of industry performance using Octagon MCP. Use when analyzing daily price movements, average changes, and performance trends for specific industries within an exchange. |
| 4 | +--- |
| 5 | + |
| 6 | +# Industry Performance Snapshot |
| 7 | + |
| 8 | +Retrieve daily industry performance data by exchange using the Octagon MCP server. |
| 9 | + |
| 10 | +## Prerequisites |
| 11 | + |
| 12 | +Ensure Octagon MCP is configured in your AI agent (Cursor, Claude Desktop, Windsurf, etc.). See [references/mcp-setup.md](references/mcp-setup.md) for installation instructions. |
| 13 | + |
| 14 | +## Workflow |
| 15 | + |
| 16 | +### 1. Identify Parameters |
| 17 | + |
| 18 | +Determine your query parameters: |
| 19 | +- **Date**: Specific trading date |
| 20 | +- **Exchange**: NYSE, NASDAQ, etc. |
| 21 | +- **Industry**: Biotechnology, Semiconductors, Software, etc. |
| 22 | + |
| 23 | +### 2. Execute Query via Octagon MCP |
| 24 | + |
| 25 | +Use the `octagon-agent` tool with a natural language prompt: |
| 26 | + |
| 27 | +``` |
| 28 | +Retrieve a daily overview of industry performance for <DATE>, filtered by exchange <EXCHANGE> and industry <INDUSTRY>. |
| 29 | +``` |
| 30 | + |
| 31 | +**MCP Call Format:** |
| 32 | + |
| 33 | +```json |
| 34 | +{ |
| 35 | + "server": "octagon-mcp", |
| 36 | + "toolName": "octagon-agent", |
| 37 | + "arguments": { |
| 38 | + "prompt": "Retrieve a daily overview of industry performance for 2025-01-09, filtered by exchange NASDAQ and industry Biotechnology." |
| 39 | + } |
| 40 | +} |
| 41 | +``` |
| 42 | + |
| 43 | +### 3. Expected Output |
| 44 | + |
| 45 | +The agent returns daily industry performance metrics: |
| 46 | + |
| 47 | +| Metric | Value | |
| 48 | +|--------|-------| |
| 49 | +| Industry | Biotechnology | |
| 50 | +| Exchange | NASDAQ | |
| 51 | +| Date | 2025-01-09 | |
| 52 | +| Average Change | +7.89% | |
| 53 | + |
| 54 | +**Interpretation**: Strong positive movement in biotechnology stocks on NASDAQ for the specified date. |
| 55 | + |
| 56 | +**Data Sources**: octagon-stock-data-agent |
| 57 | + |
| 58 | +### 4. Interpret Results |
| 59 | + |
| 60 | +See [references/interpreting-results.md](references/interpreting-results.md) for guidance on: |
| 61 | +- Evaluating daily performance magnitude |
| 62 | +- Comparing industry vs. market moves |
| 63 | +- Identifying sector rotation signals |
| 64 | +- Tracking momentum trends |
| 65 | + |
| 66 | +## Example Queries |
| 67 | + |
| 68 | +**Specific Industry and Date:** |
| 69 | +``` |
| 70 | +Retrieve a daily overview of industry performance for 2025-01-09, filtered by exchange NASDAQ and industry Biotechnology. |
| 71 | +``` |
| 72 | + |
| 73 | +**Technology Industry:** |
| 74 | +``` |
| 75 | +Get today's performance for the Semiconductor industry on NASDAQ. |
| 76 | +``` |
| 77 | + |
| 78 | +**Multiple Industries:** |
| 79 | +``` |
| 80 | +Compare daily performance of Software, Hardware, and Semiconductors on NASDAQ. |
| 81 | +``` |
| 82 | + |
| 83 | +**Historical Date:** |
| 84 | +``` |
| 85 | +What was the Biotechnology industry performance on the last FDA approval day? |
| 86 | +``` |
| 87 | + |
| 88 | +**Trend Analysis:** |
| 89 | +``` |
| 90 | +Show industry performance for Healthcare on NYSE over the past week. |
| 91 | +``` |
| 92 | + |
| 93 | +## Understanding Daily Performance |
| 94 | + |
| 95 | +### What Average Change Represents |
| 96 | + |
| 97 | +| Aspect | Description | |
| 98 | +|--------|-------------| |
| 99 | +| Definition | Average price change of stocks in industry | |
| 100 | +| Calculation | Mean of individual stock returns | |
| 101 | +| Weighting | Equal or market-cap weighted | |
| 102 | +| Timeframe | Single trading day | |
| 103 | + |
| 104 | +### Performance Levels |
| 105 | + |
| 106 | +| Change | Interpretation | |
| 107 | +|--------|----------------| |
| 108 | +| >5% | Exceptional (major catalyst) | |
| 109 | +| 2-5% | Strong move | |
| 110 | +| 0.5-2% | Moderate move | |
| 111 | +| -0.5% to +0.5% | Flat | |
| 112 | +| -2 to -0.5% | Moderate decline | |
| 113 | +| <-5% | Significant decline | |
| 114 | + |
| 115 | +## Industry Categories |
| 116 | + |
| 117 | +### Technology Industries |
| 118 | + |
| 119 | +| Industry | Typical Volatility | |
| 120 | +|----------|-------------------| |
| 121 | +| Biotechnology | High (clinical trials, FDA) | |
| 122 | +| Semiconductors | Moderate-High (cyclical) | |
| 123 | +| Software | Moderate | |
| 124 | +| IT Services | Low-Moderate | |
| 125 | +| Hardware | Moderate | |
| 126 | + |
| 127 | +### Healthcare Industries |
| 128 | + |
| 129 | +| Industry | Typical Volatility | |
| 130 | +|----------|-------------------| |
| 131 | +| Biotechnology | High | |
| 132 | +| Pharmaceuticals | Moderate | |
| 133 | +| Medical Devices | Low-Moderate | |
| 134 | +| Healthcare Services | Low | |
| 135 | + |
| 136 | +### Financial Industries |
| 137 | + |
| 138 | +| Industry | Typical Volatility | |
| 139 | +|----------|-------------------| |
| 140 | +| Banks | Moderate (rate-sensitive) | |
| 141 | +| Insurance | Low-Moderate | |
| 142 | +| Asset Management | Moderate | |
| 143 | +| Fintech | Moderate-High | |
| 144 | + |
| 145 | +## Analyzing Performance |
| 146 | + |
| 147 | +### Context Matters |
| 148 | + |
| 149 | +| Factor | Consideration | |
| 150 | +|--------|---------------| |
| 151 | +| Market direction | Industry vs. S&P 500 | |
| 152 | +| Sector performance | Industry vs. sector | |
| 153 | +| Historical range | Normal vs. unusual | |
| 154 | +| Catalyst presence | News-driven vs. rotation | |
| 155 | + |
| 156 | +### Relative Performance |
| 157 | + |
| 158 | +| Comparison | Insight | |
| 159 | +|------------|---------| |
| 160 | +| Industry > Market | Outperforming | |
| 161 | +| Industry = Market | In-line | |
| 162 | +| Industry < Market | Underperforming | |
| 163 | + |
| 164 | +### Alpha Calculation |
| 165 | + |
| 166 | +``` |
| 167 | +Alpha = Industry Return - Market Return |
| 168 | +``` |
| 169 | + |
| 170 | +Example: |
| 171 | +- Industry: +7.89% |
| 172 | +- Market: +0.5% |
| 173 | +- Alpha: +7.39% (significant outperformance) |
| 174 | + |
| 175 | +## Catalyst Analysis |
| 176 | + |
| 177 | +### Common Industry Catalysts |
| 178 | + |
| 179 | +| Catalyst | Expected Impact | |
| 180 | +|----------|-----------------| |
| 181 | +| FDA approval | Biotech +3-10% | |
| 182 | +| Earnings season | Varies | |
| 183 | +| Rate decision | Financials ±2-5% | |
| 184 | +| Product launch | Tech +1-3% | |
| 185 | +| Regulatory news | Varies | |
| 186 | + |
| 187 | +### Biotechnology Specifics |
| 188 | + |
| 189 | +| Event | Typical Response | |
| 190 | +|-------|------------------| |
| 191 | +| Phase 3 success | +5-20% | |
| 192 | +| FDA approval | +5-15% | |
| 193 | +| Clinical setback | -5-30% | |
| 194 | +| M&A announcement | +10-50% | |
| 195 | + |
| 196 | +## Momentum Analysis |
| 197 | + |
| 198 | +### Trend Signals |
| 199 | + |
| 200 | +| Pattern | Interpretation | |
| 201 | +|---------|----------------| |
| 202 | +| Multiple up days | Positive momentum | |
| 203 | +| Multiple down days | Negative momentum | |
| 204 | +| Reversal | Potential trend change | |
| 205 | +| Range-bound | Consolidation | |
| 206 | + |
| 207 | +### Follow-Through |
| 208 | + |
| 209 | +| Signal | Reliability | |
| 210 | +|--------|-------------| |
| 211 | +| High volume + strong move | Strong signal | |
| 212 | +| Low volume + strong move | Weak signal | |
| 213 | +| Continuation next day | Trend confirmation | |
| 214 | +| Reversal next day | False move | |
| 215 | + |
| 216 | +## Sector Rotation Signals |
| 217 | + |
| 218 | +### Industry Leadership |
| 219 | + |
| 220 | +| Pattern | Meaning | |
| 221 | +|---------|---------| |
| 222 | +| Cyclicals leading | Risk-on sentiment | |
| 223 | +| Defensives leading | Risk-off sentiment | |
| 224 | +| Growth leading | Optimistic outlook | |
| 225 | +| Value leading | Cautious approach | |
| 226 | + |
| 227 | +### Rotation Indicators |
| 228 | + |
| 229 | +| Observation | Interpretation | |
| 230 | +|-------------|----------------| |
| 231 | +| Biotech surging | Speculative appetite | |
| 232 | +| Utilities leading | Flight to safety | |
| 233 | +| Banks rallying | Rate expectations | |
| 234 | +| Tech selling off | Growth concerns | |
| 235 | + |
| 236 | +## Exchange Considerations |
| 237 | + |
| 238 | +### NASDAQ Characteristics |
| 239 | + |
| 240 | +| Factor | Impact | |
| 241 | +|--------|--------| |
| 242 | +| Tech-heavy | More volatile | |
| 243 | +| Growth-oriented | Bigger moves | |
| 244 | +| Biotech concentration | FDA-sensitive | |
| 245 | + |
| 246 | +### NYSE Characteristics |
| 247 | + |
| 248 | +| Factor | Impact | |
| 249 | +|--------|--------| |
| 250 | +| More diversified | Moderate volatility | |
| 251 | +| Large-cap focus | Steadier moves | |
| 252 | +| Traditional industries | Less speculative | |
| 253 | + |
| 254 | +## Common Use Cases |
| 255 | + |
| 256 | +### Daily Monitoring |
| 257 | +``` |
| 258 | +How did Biotechnology perform today? |
| 259 | +``` |
| 260 | + |
| 261 | +### Catalyst Research |
| 262 | +``` |
| 263 | +What was the industry reaction to the FDA announcement? |
| 264 | +``` |
| 265 | + |
| 266 | +### Sector Rotation |
| 267 | +``` |
| 268 | +Which industries are leading the market today? |
| 269 | +``` |
| 270 | + |
| 271 | +### Historical Analysis |
| 272 | +``` |
| 273 | +What was industry performance during last quarter's earnings season? |
| 274 | +``` |
| 275 | + |
| 276 | +### Momentum Tracking |
| 277 | +``` |
| 278 | +Is the Semiconductor industry showing positive momentum this week? |
| 279 | +``` |
| 280 | + |
| 281 | +## Analysis Tips |
| 282 | + |
| 283 | +1. **Compare to market**: Industry move vs. S&P 500/NASDAQ. |
| 284 | + |
| 285 | +2. **Check for catalysts**: News explains unusual moves. |
| 286 | + |
| 287 | +3. **Consider volatility**: Biotech ±5% is normal, utilities ±5% is not. |
| 288 | + |
| 289 | +4. **Track trends**: One day is noise, multiple days is signal. |
| 290 | + |
| 291 | +5. **Volume matters**: High volume confirms moves. |
| 292 | + |
| 293 | +6. **Look at breadth**: How many stocks participated? |
| 294 | + |
| 295 | +## Integration with Other Skills |
| 296 | + |
| 297 | +| Skill | Combined Use | |
| 298 | +|-------|--------------| |
| 299 | +| sector-performance-snapshot | Broader sector context | |
| 300 | +| industry-pe-ratios | Valuation with performance | |
| 301 | +| stock-performance | Individual stock details | |
| 302 | +| stock-quote | Current prices | |
0 commit comments